Researchers at Tel Aviv University have developed a new platform using polymeric nanoparticles to deliver drug pairs to specific cancer types, including skin cancer and breast cancer. The researchers ...

Aviceda Therapeutics has secured $207.5 million in series C funds as the immunomodulator-focused biotech awaits a phase 3 ...

Researchers at Tel Aviv University have developed a new platform using polymeric nanoparticles to deliver drug pairs to specific cancer types, including skin cancer and breast cancer.

T endons are the small but tough linkers between bones and muscle. When they are injured, repairing a tendon is no small task ...

Vertex aims to further bolster its gene-editing therapy pipeline by using Orna's lipid nanoparticle delivery technologies during the three-year collaboration.

Novel peptide-modified lipid nanoparticles can cross the blood–brain barrier and target neurons, taking one step closer to ...

Silver nanoparticles (AgNPs) are widely used in medicine for their antimicrobial and drug delivery properties, but their toxicity has raised concerns. In a recent research published in Nano ...

With years of experience in the Pharmaceutical and life science sectors, CD Bioparticles announces the launch of its new line ...

Researchers develop inhalable nanoparticles for lung cancer treatment inspired by mussels New technology transforms lung ...

In collaboration with European counterparts, researchers from Tel Aviv University have introduced a novel dual-drug ...